Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Werner, N.
Right arrow Articles by Nickenig, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Werner, N.
Right arrow Articles by Nickenig, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


AT1 receptors in atherosclerosis: biological effects including growth, angiogenesis, and apoptosis

N. Werner and G. Nickenig*

Medizinische Klinik und Poliklinik, Innere Medizin III (Kardiologie/Angiologie), Universitätskliniken des Saarlandes, Homburg/Saar, Germany

* Dr. Georg Nickenig, Medizinische Klinik und Poliklinik, Innere Medizin III (Kardiologie/Angiologie), Universitätskliniken des Saarlandes, 66421 Homburg/Saar, Germany.

Abstract

Several recent studies have demonstrated a pivotal role of angiotensin II in the development of atherosclerosis, myocardial infarction, vascular and myocardial remodelling, and congestive heart failure. AT1 receptor-evoked oxidative stress has been implicated in all states of atherosclerosis, starting with the development of endothelial dysfunction and ultimately leading to plaque rupture and myocardial infarction. There is a broad body of evidence showing that growth and apoptosis of vascular smooth muscle and endothelial cells and unrestricted intra-plaque angiogenesis predis[ose to an accelerated onset and progression of atherosclerosis. The potent anti-atherosclerotic effects of inhibition of the renin angiotensin system by ACE inhibitors and AT1 receptor antagonists are, at least in part, based on their interference with apoptotic and angiogenic processes leading ultimately to plaque stabilization and reduced coronary event rates.

Key Words: angiotensin II • AT1 receptor • reactive oxygen species • atherosclerosis • angiogenesis • apoptosis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.